In addition, several studies have shown that TILs are an important indicator of the outcome of triple-negative breast cancer (TNBC) and HER2-positive BC (4, 14–16), but the prognostic effect and clinical significance of TILs in HER2-low-positive BC have not been reported. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.